Syncom Formulations (India) Ltd Share Price
(SYNCOMF)
₹16.81
as on 04:01PM, 29 Apr 2025
Syncom Formulations (India) Ltd Performance
Day's Low
Day's High
₹16.6Day's Price Range₹17.2652 Week's Low
52 Week's High
₹10.9552-Week Price Range₹27.9
| Returns % | |
| 1 Month Return | -1.75 % |
| 3 Month Return | -4.65 % |
| 1 Year Return | + 23.15 % |
| Market Stats | |
| Previous Close | ₹16.90 |
| Open | ₹16.91 |
| Volume | 17.75L |
| Upper Circuit | ₹20.28 |
| Lower Circuit | ₹13.52 |
| Market Cap | ₹1,580.14Cr |
Syncom Formulations (India) Ltd Fundamentals
P/E Ratio
32.96
PEG Ratio
193.89
Market Cap
₹1,580.14 Cr
P/B Ratio
3.67
EPS
0.27
Dividend Yield
0Sector
Pharmaceuticals
ROE
8.71
Mutual Fund Holdings of Syncom Formulations (India) Ltd
| Funds | Holdings | Prev. 5M |
|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct Growth | 0.06% |
Key events for Syncom Formulations (India) Ltd
Syncom Formulations Reports Strong Q3FY25 Growth - 20 Apr, 2025
In Q3FY25, Syncom Formulations reported a 25% increase in revenue from Rs 101 crores to Rs 127 crores, while net profits rose 18% from Rs 11 crores to Rs 13 crores. The current share price is Rs 17.56, with a market capitalization of Rs 1,633.72 crores and yearly stock returns of 38.81%.
Insights on Syncom Formulations (India) Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 49.30% to 49.32% in Mar 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 7 quarters, 4.4 Cr → 13.0 Cr (in ₹), with an average increase of 15.6% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 7 quarters, 61.71 Cr → 131.57 Cr (in ₹), with an average increase of 11.7% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 80.4%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.57% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 29.1%
NEGATIVE IMPACTPrice Dip
In the last 7 days, SYNCOMF stock has moved down by -5.4%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 0.13% to 0.11% in Mar 2025 quarter
Syncom Formulations (India) Ltd Financials
Syncom Formulations (India) Ltd Index Inclusions
Syncom Formulations (India) Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.57% | 0.00 | |
| Foreign Institutions | 0.11% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 49.32% | 0.00 | |
| Others | 0% | 0.00 |
Syncom Formulations (India) Ltd Key Indicators
Syncom Formulations (India) Ltd Valuation
Syncom Formulations (India) Ltd in the last 5 years
Lowest (3.98x)
March 12, 2020
Today (32.96x)
April 29, 2025
Industry (54.77x)
April 29, 2025
Highest (81.74x)
January 18, 2022
Syncom Formulations (India) Ltd Earnings and Dividends
Syncom Formulations (India) Ltd Earnings Results
Syncom Formulations (India) Ltd’s net profit jumped 85.71% since last year same period to ₹13Cr in the Q3 2024-2025. On a quarterly growth basis, Syncom Formulations (India) Ltd has generated 17.01% jump in its net profits since last 3-months.
Read More about Earnings ResultsSyncom Formulations (India) Ltd Dividends August,2022
In the quarter ending June 2022, Syncom Formulations (India) Ltd has declared dividend of ₹0.03 - translating a dividend yield of 0.18%.
Read More about Dividends
Syncom Formulations (India) Ltd Technicals Summary
Bearish
Neutral
Bullish
Syncom Formulations (India) Ltd is currently in a Bearish trading position according to technical analysis indicators.
Syncom Formulations (India) Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,580.14 Cr | 316.2% | 0.61 | ₹25 Cr | ₹263 Cr | |
| NA | ₹147.07 Cr | 35.43% | 0.62 | NA | NA | |
| NA | ₹5,411.31 Cr | 432.02% | 0.50 | ₹33 Cr | ₹204 Cr | |
| NA | ₹1,510.04 Cr | 381.87% | 0.52 | NA | NA | |
| NA | ₹3,596.41 Cr | 157.18% | 0.51 | NA | NA |
About Syncom Formulations (India) Ltd
Revenue: ₹127.53Cr as on December 2024 (Q4 24)
Net Profit: ₹13.00Cr as on December 2024 (Q4 24)
Listing date: 18 Nov, 2022
Chairperson Name: Kedarmal Bankda
| Organisation | Syncom Formulations (India) Ltd |
| Headquarters | Indore |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Syncom Formulations (India) Ltd
What is Syncom Formulations (India) Ltd price today?
Syncom Formulations (India) Ltd share price today stands at ₹16.81, Open: ₹16.91, Previous Close: ₹16.9, High: ₹17.26, Low: ₹16.6, 52 Week High: ₹27.9, 52 Week Low: ₹10.95.
How to Buy Syncom Formulations (India) Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Syncom Formulations (India) Ltd shares
What are today's traded volumes of Syncom Formulations (India) Ltd?
Today's traded volume of Syncom Formulations (India) Ltd(SYNCOMF) is 17.75L.
What is today's market capitalisation of Syncom Formulations (India) Ltd?
Today's market capitalisation of Syncom Formulations (India) Ltd(SYNCOMF) is ₹1580.14Cr.
What is the 52 Week High and Low Range of Syncom Formulations (India) Ltd?
How much percentage Syncom Formulations (India) Ltd is down from its 52 Week High?
Syncom Formulations (India) Ltd (SYNCOMF) share price is ₹16.81. It is down -39.75% from its 52 Week High price of ₹27.9
How much percentage Syncom Formulations (India) Ltd is up from its 52 Week low?
Syncom Formulations (India) Ltd (SYNCOMF) share price is ₹16.81. It is up 53.52% from its 52 Week Low price of ₹10.95